- Category
- Micro (2021-22)
- Udyam number
- UDYAM-WB-03-0001464

Andinil Pharmaceuticals Private Limited
About Andinil Pharmaceuticals Private Limited
Data last updated:
Andinil Pharmaceuticals Private Limited is a private limited company based in Burdwan, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 December 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24290WB2020PTC242129. Its GSTIN is 19AAUCA5529P1ZO (West Bengal).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Indrani Ghosh and Swapnanil Ghosh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 39 G. T. Road Birhata Purba Burdwan, West Bengal, India – 713101.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.81 Lakh, a decline of 45% compared to the previous year. For the same year it recorded a net profit of ₹8,577 (net margin 3.1%) and EBITDA of ₹21,440 (EBITDA margin 7.6%).
Andinil Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-03-0001464).
Company details
Recognitions & Rankings of Andinil Pharmaceuticals
Contact details
Andinil Pharmaceuticals Private Limited's registered office is in Burdwan, West Bengal.
- Registered Address39 G. T. Road Birhata Purba Burdwan, West Bengal, India – 713101
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Andinil Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Andinil Pharmaceuticals Private Limited, buy the company report.
Financials of Andinil Pharmaceuticals Private Limited
FY 2025 filings availableAndinil Pharmaceuticals Private Limited reported revenue of ₹2.81 Lakh (down 45% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 45% in the latest year. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹21,440 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8,577 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.6% | ||||
| Net Profit Margin | 3.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Andinil Pharmaceuticals Private Limited, buy the company report.
Board of directors of Andinil Pharmaceuticals Private Limited
Andinil Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Swapnanil Ghosh | Additional Director | 04 Dec 2023 | 2 Years 11 Months | Current |
| Indrani Ghosh | Director | 21 Dec 2020 | 5 Years 10 Months | Current |
Peer comparison
Andinil Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Andinil Pharmaceuticals Private Limitedthis company | ₹2.81 Lakh (FY 2025) | ₹8,577 | 3.1% | -45.0% | Burdwan, West Bengal, India | |
| Centriole Pharmaceuticals Private Limited | ₹2.81 Lakh (FY 2022) | Pune, Maharashtra, India | ||||
| Million Health Pharmaceuticals Private Limited | ₹2.8 Lakh (FY 2021) | Mumbai, Maharashtra, India | ||||
| Adventure Pharmaceuticals Private Limited | ₹2.8 Lakh (FY 2025) | -48.0% | Patna, Bihar, India |
To see the full peer comparison of Andinil Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Andinil Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Andinil Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Andinil Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAUCA5529P1ZO | West Bengal | Active | 31 Aug 2021 |
To see the full GST registrations and return filing status of Andinil Pharmaceuticals Private Limited, buy the company report.
Recent activity
Andinil Pharmaceuticals Private Limited has 3 board changes on record since 2020: 2 appointments and 1 cessation. The latest: Swapnanil Ghosh was appointed as Additional Director on 04 Dec 2023.
Frequently asked questions
Andinil Pharmaceuticals is an active private limited company based in Burdwan, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 December 2020 (6+ years old) and is registered under CIN U24290WB2020PTC242129.
Andinil Pharmaceuticals has 2 current directors:
- Swapnanil Ghosh - Additional Director
- Indrani Ghosh - Director
The latest financial statements of Andinil Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Andinil Pharmaceuticals is 19AAUCA5529P1ZO, registered in West Bengal.
The CIN (Corporate Identification Number) of Andinil Pharmaceuticals is U24290WB2020PTC242129. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Andinil Pharmaceuticals was incorporated on 21 December 2020, making it 6+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Andinil Pharmaceuticals by revenue are Centriole Pharmaceuticals Private Limited, Million Health Pharmaceuticals Private Limited, Adventure Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Swapnanil Ghosh was appointed as Additional Director on 04 Dec 2023. Anjali Pan ceased to be Director on 29 Sep 2023. Indrani Ghosh was appointed as Director on 21 Dec 2020.
Yes, Andinil Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-WB-03-0001464).
The registered office of Andinil Pharmaceuticals is at 39 G. T. Road Birhata Purba Burdwan, West Bengal, India – 713101.
Andinil Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

